MyFinsight

HomeBlogAboutContact

MyFinsight

Making company financials insightful for everyone

Quick Links

  • About
  • Blog
  • Contact

Follow Us

  • X.com
  • Thread
  • Instagram

© 2026 MyFinsight. All rights reserved.

|||

For the year ending 2025-12-31, IDYA had $28,657K increase in cash & cash equivalents over the period. -$73,466K in free cash flow.

Cash Flow Overview

Change in Cash
$28,657K
Free Cash flow
-$73,466K
Unit: Thousand (K) dollars
Positive Cash Flow Breakdown
    • Maturities of marketable securit...
    • Stock-based compensation
    • Proceeds from issuance of common...
    • Others
Negative Cash Flow Breakdown
    • Purchases of marketable securiti...
    • Net loss
    • Net amortization (accretion) of ...
    • Others

Cash Flow
2025-12-31
Net loss
-113,698
Depreciation and amortization
2,700
Net amortization (accretion) of premiums (discounts) on marketable securities
9,976
Stock-based compensation
46,115
Amortization of right of use assets
1,893
Accounts receivable
0
Prepaid expenses and other assets
7,840
Accounts payable
2,697
Accrued and other liabilities
10,427
Contract assets and liabilities
5,973
Lease liabilities
2,557
Net cash used in operating activities
-71,098
Purchases of property and equipment, net
2,368
Purchases of marketable securities
607,889
Maturities of marketable securities
680,233
Net cash provided by (used in) investing activities
69,976
Proceeds from issuance of common stock in public offering, net of issuance costs
0
Proceeds from issuances of pre-funded warrants
0
Proceeds from issuance of common stock related to at-the-market offering program, net of issuance costs
24,855
Proceeds from exercise of common stock options
3,431
Proceeds from espp purchases
1,493
Net cash provided by financing activities
29,779
Net increase (decrease) in cash, cash equivalents and restricted cash
28,657
Cash and cash equivalents at beginning of period
85,183
Cash and cash equivalents at end of period
113,840
Unit: Thousand (K) dollars (except for numbers of shares and EPS).

Time Plot

Show the time plot by selecting a row from the table.

Cash Flow

Maturities of marketablesecurities$680,233K Proceeds from issuance ofcommon stock related to...$24,855K Proceeds from exercise ofcommon stock options$3,431K Proceeds from espppurchases$1,493K Net cash provided by(used in) investing...$69,976K Net cash provided byfinancing activities$29,779K Canceled cashflow$610,257K Net increase(decrease) in cash, cash...$28,657K Canceled cashflow$71,098K Purchases of marketablesecurities$607,889K Purchases of property andequipment, net$2,368K Stock-based compensation$46,115K Accrued and otherliabilities$10,427K Depreciation andamortization$2,700K Accounts payable$2,697K Lease liabilities$2,557K Amortization of right of useassets$1,893K Net cash used inoperating activities-$71,098K Canceled cashflow$66,389K Net loss-$113,698K Net amortization(accretion) of premiums...$9,976K Prepaid expenses andother assets$7,840K Contract assets andliabilities$5,973K

IDEAYA Biosciences, Inc. (IDYA)

IDEAYA Biosciences, Inc. (IDYA)